An analysis that corrected for differences in implementation found that the two main trials of prostate cancer screening in Europe and the United States both show a reduction in prostate cancer mortality with screening.
Annual mammography screening starting at age 40 prevents the most breast cancer deaths, according to a comparison of the three most common screening recommendations.
Computed tomography (CT) screening for lung cancer could lead to increased rates of smoking cessation in a high-risk population, with this “teachable moment” extending even to those with negative scan results.
Adherence to screening protocols at cancer centers resulted in fewer emergency department visits and hospitalizations in the 2-month period after the screening.
The higher prostate cancer death rates seen among black men in the United States may be due to a higher incidence of preclinical disease and higher risk of metastatic progression, suggesting that different screening policies could benefit this population.
Understanding the Links Between Lung Cancer, COPD, and Emphysema: A Key to More Effective Treatment and Screening
A better delineation of the relationships between lung cancer, COPD, and emphysema may lead to significant improvements in the effectiveness of lung cancer screening programs, and to reductions in the morbidity and mortality associated with these deadly diseases.
The use of mammography, but not colonoscopy, has increased in the post–Affordable Care Act years, which eliminated out-of-pocket expenditures for these recommended services, according to the results of a new study.
Breast cancer screening was not associated with any reduction in the incidence of advanced cancer, and overdiagnosis of invasive tumors and ductal carcinoma in situ is a common problem, according to a new study conducted in Denmark.
An increasing percentage of men over the age of 75 who are diagnosed with prostate cancer have distant metastases at the time of diagnosis, according to a new study.
This Medical News Minute outlines efforts by a number of advocacy groups and medical associations urging the CMS to abandon proposed reimbursement cuts to low-dose CT screening for lung cancer.